| A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target ZT Freeman, TR Nirschl, DH Hovelson, RJ Johnston, JJ Engelhardt, ... The Journal of clinical investigation 130 (3), 1405-1416, 2020 | 78 | 2020 |
| Associations between mixtures of urinary phthalate metabolites with gestational age at delivery: a time to event analysis using summative phthalate risk scores J Boss, J Zhai, MT Aung, KK Ferguson, LE Johns, TF McElrath, JD Meeker, ... Environmental Health 17, 1-13, 2018 | 37 | 2018 |
| Rationale for using irreversible epidermal growth factor receptor inhibitors in combination with phosphatidylinositol 3-kinase inhibitors for advanced head and neck squamous … NL Michmerhuizen, E Leonard, C Matovina, M Harris, G Herbst, ... Molecular pharmacology 95 (5), 528-536, 2019 | 20 | 2019 |
| Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high‐risk patients CG Castillo, CA Kauffman, J Zhai, H Jiang, SM Agozino, MH Miceli Mycoses 61 (1), 4-10, 2018 | 20 | 2018 |
| Validation of a serum 4-microRNA signature for the detection of lung cancer X Yang, W Su, X Chen, Q Geng, J Zhai, H Shan, C Guo, Z Wang, H Fu, ... Translational Lung Cancer Research 8 (5), 636, 2019 | 16 | 2019 |
| Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene ME Heft Neal, AC Birkeland, AD Bhangale, J Zhai, A Kulkarni, SK Foltin, ... BMC cancer 21 (1), 636, 2021 | 11 | 2021 |
| Rationale for the advancement of PI3K pathway inhibitors for personalized chordoma therapy NL Michmerhuizen, JH Owen, ME Heft Neal, JE Mann, E Leonard, ... Journal of Neuro-oncology 147, 25-35, 2020 | 11 | 2020 |
| Integrative sequencing discovers an ATF1-motif enriched molecular signature that differentiates hyalinizing clear cell carcinoma from mucoepidemoid carcinoma MEH Neal, E Gensterblum-Miller, AD Bhangale, A Kulkarni, J Zhai, ... Oral oncology 117, 105270, 2021 | 6 | 2021 |
| Microbe-mediated activation of toll-like receptor 2 drives PDL1 expression in HNSCC JE Mann, ML Ludwig, A Kulkarni, EB Scheftz, IR Murray, J Zhai, ... Cancers 13 (19), 4782, 2021 | 5 | 2021 |
| Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma NL Michmerhuizen, ML Ludwig, AC Birkeland, S Nimmagadda, J Zhai, ... Head & neck 44 (5), 1192-1205, 2022 | 4 | 2022 |
| Advancement of PI3 kinase inhibitor combination therapies for PI3K-aberrant chordoma MEH Neal, NL Michmerhuizen, KJ Kovatch, JHJ Owen, J Zhai, H Jiang, ... Journal of Neurological Surgery Part B: Skull Base, 087-098, 2020 | 2 | 2020 |
| Rationale for using irreversible EGFR Inhibitors in combination with PI3K inhibitors for advanced Head and Neck Squamous Cell Carcinoma NL Michmerhuizen, E Leonard, C Matovina, M Harris, G Herbst, ... Molecular Pharmacology, 2019 | 2 | 2019 |
| A Genome Wide CRISPR Profiling Approach Identifies Mechanisms of Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma M Ludwig, A Birkeland, J Smith, E Gensterblum-Miller, JI Zhai, A Kulkarni, ... | | 2024 |
| Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinoma ML Ludwig, NL Michmerhuizen, J Wang, AC Birkeland, BK Majchrowski, ... Archives of Oral Biology 156, 105822, 2023 | | 2023 |
| Reconstruction of Single-Cell Trajectories Using Stochastic Tree Search J Zhai, H Ji, H Jiang Genes 14 (2), 318, 2023 | | 2023 |
| Two‐sample test with g‐modeling and its applications J Zhai, H Jiang Statistics in Medicine 42 (1), 89-104, 2023 | | 2023 |
| Statistical Methods for Gene Differential Expression Detection and Cell Trajectory Reconstruction from Single-Cell RNA Sequencing Data J Zhai | | 2022 |
| Discovery of synergistic PI3K inhibitor combination therapies using high throughput approaches in HNSCC NL Michmerhuizen, E Leonard, C Heenan, V Nair, C Matovina, M Harris, ... Cancer Research 79 (13_Supplement), 322-322, 2019 | | 2019 |
| Abstract LB-118: A conserved checkpoint molecule signature offers novel targets for tumor specific regulatory T cell manipulation ZT Freeman, DH Hovleson, AT Pearson, J Zhai, A Ghasemzadeh, ... Cancer Research 78 (13_Supplement), LB-118-LB-118, 2018 | | 2018 |
